Home Ad Exchange News Health Care Marketing Must Adapt To Grow

Health Care Marketing Must Adapt To Grow

SHARE:

This piece is part of a series on targeted health care marketing, highlighting stories from people in the trenches throughout the industry. Read the first, second and third stories in the series.

Bias and lack of diversity are deeply baked into health care organizations. They aren’t bugs; they’re features.

Zooming out from health care to the data underlying marketing efforts, it is fundamentally flawed because of a lack of representation in clinical research. Socioeconomically disadvantaged populations and ethnic minorities are underrepresented and have been historically excluded from studies or ignored outright.

The Institutional Research Board’s federal regulations designate racial and ethnic minorities among its vulnerable populations, which tacitly acknowledges that, in the past, these groups experienced great harm as research participants.

Both health care and marketing leaders are predominantly white. Not only that, but too often these decision-makers sit in corporate bubbles, detached from the customers they’re trying to connect.

“They don’t have a spectrum of diversity in their office,” said Albert Thompson, managing director of digital at full-service ad agency Walton Isaacson. “They don’t even know what it looks like.”

Health care organizations need to embrace fluidity and experimentation if they want to market to the diverse US population they rely on to survive.

“I don’t think the sector has woken up and realized, ‘We are the problem,’” he said. “They always say, ‘If you want to sell more product, design the next consumer.’ All these health care companies have product, but they didn’t design their future consumer, who was largely someone of color.”

Thompson spoke with AdExchanger.

AdExchanger: How do you approach race-based targeting in health care marketing in a nuanced, respectful way?

ALBERT THOMPSON: You can do third-party research. You can do ethnographies. It comes through somewhat in clinical trials and brand health studies. You can partner with media companies that already cover those audiences and do a study to really understand how [underserved] segments identify.

Marketing is about consumer intimacy and knowing who you’re dealing with. Consumer marketers have to start spending more money on research and less on product development and placement. The starting point is understanding the consumer, and that could take years. You have to spend the time; you have to do the work.

How do you segment audiences? How granular can you get?

The persona is usually the first route. Once you get to the persona mapping and tying that to product lines and services, you start to understand who’s emerging.

Personas really get you into the psychological tracks of how people think. Sometimes it cuts across [ethnic groups]. The persona may evolve into a journey map or patient pathway. If you don’t understand why somebody makes the decision to pursue therapy treatment around a disease class and how they make the decision to ultimately buy, I don’t know if you can do segmentation very well.

How can influencer marketing be useful for pharmaceutical or health care marketing?

Influencers carry the currency of one-to-one validation and credibility. Influencer marketing plays on all the moments of truth the way traditional marketing never can. That’s how human beings work. Most of the people we speak to and trust are in a very close circle, and brands typically are not part of that circle.

What can health care marketers learn from other industries?

No one in health care is stealing lessons from each other. In other industries – like fashion, entertainment, music, film – people look at the successes and they mimic it, or they reboot old stuff because it will do well. Automotive does an amazing job of mimicking its competitors.

There’s also an underutilization of health care’s gateway categories. Health care doesn’t sit on an island. Physical fitness is a gateway to preventative medicine. Insurance is a sister category; your level of health has a lot to do with what degree you’re insurable or whether you get certain types of insurance. Other verticals have tethered themselves to other industries. Health care doesn’t do some of these basic tenets at real scale.

This interview has been edited and condensed.

For more articles featuring Albert Thompson , click here.

Must Read

Why Wall Street Turned Against The Trade Desk

The Trade Desk is less than a third as valuable as it was a year ago. It retains about one-tenth of its high-water market cap from December 2024, when the company was worth almost $70 billion. Why did investors lose the faith?

Garrett McGrath, President, Prebid.org

Prebid’s New President Is Its Former Chairman, Garrett McGrath

McGrath left Prebid in June following five years as board chairman after stepping down as SVP of product management at Magnite. But now, overseeing Prebid will be his full-time job.

TV Manufacturer Telly Touts Programmatic Home Screen Ads

Telly, the startup that gives away free smart TVs in exchange for data and ad exposure, is making its home screen ads available for brands to buy programmatically – and pushing for industry standards to help attract more spend. 

Privacy! Commerce! Connected TV! Read all about it. Subscribe to AdExchanger Newsletters

AI Is Helping L’Oréal Brainstorm Unique Ways To Reach Male Audiences

L’Oréal adopted creative AI platform Springboards to generate creative ideas that led to a collaborative, ongoing ideation process.

AdExchanger's Big Story podcast with journalistic insights on advertising, marketing and ad tech

Google Had Its Day In Court. Now, It’s Amazon’s Turn

Google won’t have to break up its ads business after being declared an online monopolist. Meanwhile, Amazon faces a lawsuit from the FTC alleging that it charged advertisers more than necessary for ecommerce ads.

The FTC’s Amazon Lawsuit Is Ad Tech’s History Of Opacity Repeating Itself

Buy-side experts said it’s another example of a Big Tech platform taking advantage of the lack of transparency built into programmatic ad auctions. And they’re not optimistic change is coming.